Organometallic compound and organic light-emitting device including the same
US-2020280003-A1 · Sep 3, 2020 · US
US11807654B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11807654-B2 |
| Application number | US-202016744481-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 16, 2020 |
| Priority date | May 10, 2019 |
| Publication date | Nov 7, 2023 |
| Grant date | Nov 7, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An organometallic compound represented by Formula 1, an organic light-emitting device including the organometallic compound, and a diagnostic composition including the organometallic compound: M 11 (L 11 ) n11 (L 12 ) n12 Formula 1 wherein, in Formula 1, M 11 is a first-row transition metal, a second-row transition metal, or a third-row transition metal, L 11 is a ligand represented by Formula 1-1, L 12 is a monodentate ligand or a bidentate ligand, n11 is 1, and n12 is 0, 1, or 2: wherein, in Formula 1-1, Y 11 , A 11 , T 11 k11, k12, k13, b11, E 11 to E 13 and R 11 to R 17 are described in the specification, and *1 to *4 each independently indicate a binding site to M 11 .
Opening claim text (preview).
What is claimed is: 1. An organometallic compound represented by Formula 1: M 11 (L 11 ) n11 (L 12 ) n12 Formula 1 wherein, in Formula 1, M 11 is a first-row transition metal, a second-row transition metal, or a third-row transition metal, L 11 is a ligand represented by Formula 1-1, L 12 is a monodentate ligand or a bidentate ligand, n11 is 1, and n12 is 0, 1, or 2: wherein, in Formula 1-1, Y 11 is C or N, A 11 is of Formulae 2-2 to 2-20, 2-22 to 2-36 and 2-38 to 2-47: wherein, in Formulae 2-2 to 2-20, 2-22 to 2-36 and 2-38 to 2-47, X 24 is N or C(R 24 ), X 25 is N or C(R 25 ), X 26 is N or C(R 26 ), X 27 is N or C(R 27 ), b21 is an integer from 1 to 8, *4 indicates a binding site to M 11 , and * indicates a binding site to an adjacent atom, T 11 is C(R 16 )(R 17 ), Si(R 16 )(R 17 ), O, S, B(R 16 ), or N(R 16 ), k11 is 0, 1, 2, or 3, k12 is 0, 1, or 2, k13 is 0, 1, 2, 3, or 4, the sum of k11 to k13 is 1 or greater, E 11 to E 13 are each independently hydrogen, deuterium, —F, —Cl, —Br, —I, —SF 5 , a hydroxyl group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 2 -C 10 heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 7 -C 60 alkyl aryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, a substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted C 2 -C 60 alkyl heteroaryl group, a substituted or unsubstituted C 1 -C 60 heteroaryloxy group, a substituted or unsubstituted C 1 -C 60 heteroarylthio group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —Si(Q 1 )(Q 2 )(Q 3 ), —B(Q 1 )(Q 2 ), —N(Q 1 )(Q 2 ), —P(Q 1 )(Q 2 ), —C(═O)(Q 1 ), —S(═O)(Q 1 ), —S(═O) 2 (Q 1 ), —P(═O)(Q 1 )(Q 2 ), or —P(═S)(Q 1 )(Q 2 ), wherein two adjacent groups of E 11 to E 13 are optionally bound to form a substituted or unsubstituted C 5 -C 30 carbocyclic group or a substituted or unsubstituted C 1 -C 30 heterocyclic group, R 11 to R 17 , R 21 , and R 24 to R 27 are each independently hydrogen, deuterium, —F, —Cl, —Br, —I, —SF 5 , a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 2 -C 10 heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 7 -C 60 alkyl aryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, a substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted C 2 -C 60 alkyl heteroaryl group, a substituted or unsubstituted C 1 -C 60 heteroaryloxy group, a substituted or unsubstituted C 1 -C 60 heteroarylthio group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —Si(Q 1 )(Q 2 )(Q 3 ), —B(Q 1 )(Q 2 ), —N(Q 1 )(Q 2 ), —P(Q 1 )(Q 2 ), —C(═O)(Q 1 ), —S(═O)(Q 1 ), —S(═O) 2 (Q 1 ), —P(═O)(Q 1 )(Q 2 ), or —P(═S)(Q 1 )(Q 2 ), wherein two adjacent groups R 12 to R 15 are optionally bound to form a substituted or unsubstituted C 5 -C 30 carbocyclic group or a substituted or unsubstituted C 1 -C 30 heterocyclic group, R 22 and R 23 are each independently hydrogen, b11 is 1, 2, 3, 4, 5, 6, 7, or 8, wherein Q 1 to Q 3 are each independently hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 7 -C 60 alkyl aryl group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 1 -C 60 heteroaryl group, a C 2 -C 60 alkyl heteroaryl group, a C 1 -C 60 heteroaryloxy group, a C 1 -C 60 heteroarylthio group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, a C 1 -C 60 alkyl group substituted with at least one deuterium, —F, a cyano group, a C 1 -C 60 alkyl group, or a C 6 -C 60 aryl group, or a C 6 -C 60 aryl group substituted with at least one deuterium, —F, a cyano group, a C 1 -C 60 alkyl group, or a C 6 -C 60 aryl group, and *1 to *4 each independently indicate a binding site to M 11 . 2. The organometallic compound of claim 1 , wherein a moiety represented by is represented by any one of Formulae 3-1 to 3-8: wherein, in Formulae 3-1 to 3-8, E 11a , E 11b , and E 11c are each understood by referring to the description of E 11 in Formula 1-1, *1 indicates a binding site to M 11 , and * and *′ each indicate a binding site to an adjacent atom. 3. The organometallic compound of claim 2 , wherein a moiety represented by is represented by any one of Formulae 3-1 to 3-4. 4. The organometallic compound of claim 1 , wherein a moiety represented by is represented by any one of Formulae 4-1 to 4-42:
Platinum compounds · CPC title
comprising platinum · CPC title
characterised by the electroluminescent [EL] layers · CPC title
Triplet emission · CPC title
containing organic luminescent materials · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.